1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Tate, S. Tate, N.U. Ushioda, T. Samejima, T. Kainosho, M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 34 14637 14648 10.1021/bi00045a004 7578072 Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A. 1995 10.2210/pdb1cyv/pdb pdb_00001cyv 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11002.426 CYSTATIN A DEL(M1), M65L 1 man polymer STEFIN A no no MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAGDNKYLHLKVFKSLPGQNEDL VLTGYQVDKNKDDELTGF MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAGDNKYLHLKVFKSLPGQNEDL VLTGYQVDKNKDDELTGF A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_database_related pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1995-12-07 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_related.content_type _pdbx_database_related.details _pdbx_database_status.process_site _struct_ref_seq_dif.details ensemble Y BNL 1995-08-24 REL 1 BRUNGER refinement X-PLOR 3.1 MET 1 n 1 MET 1 A ILE 2 n 2 ILE 2 A PRO 3 n 3 PRO 3 A GLY 4 n 4 GLY 4 A GLY 5 n 5 GLY 5 A LEU 6 n 6 LEU 6 A SER 7 n 7 SER 7 A GLU 8 n 8 GLU 8 A ALA 9 n 9 ALA 9 A LYS 10 n 10 LYS 10 A PRO 11 n 11 PRO 11 A ALA 12 n 12 ALA 12 A THR 13 n 13 THR 13 A PRO 14 n 14 PRO 14 A GLU 15 n 15 GLU 15 A ILE 16 n 16 ILE 16 A GLN 17 n 17 GLN 17 A GLU 18 n 18 GLU 18 A ILE 19 n 19 ILE 19 A VAL 20 n 20 VAL 20 A ASP 21 n 21 ASP 21 A LYS 22 n 22 LYS 22 A VAL 23 n 23 VAL 23 A LYS 24 n 24 LYS 24 A PRO 25 n 25 PRO 25 A GLN 26 n 26 GLN 26 A LEU 27 n 27 LEU 27 A GLU 28 n 28 GLU 28 A GLU 29 n 29 GLU 29 A LYS 30 n 30 LYS 30 A THR 31 n 31 THR 31 A ASN 32 n 32 ASN 32 A GLU 33 n 33 GLU 33 A THR 34 n 34 THR 34 A TYR 35 n 35 TYR 35 A GLY 36 n 36 GLY 36 A LYS 37 n 37 LYS 37 A LEU 38 n 38 LEU 38 A GLU 39 n 39 GLU 39 A ALA 40 n 40 ALA 40 A VAL 41 n 41 VAL 41 A GLN 42 n 42 GLN 42 A TYR 43 n 43 TYR 43 A LYS 44 n 44 LYS 44 A THR 45 n 45 THR 45 A GLN 46 n 46 GLN 46 A VAL 47 n 47 VAL 47 A VAL 48 n 48 VAL 48 A ALA 49 n 49 ALA 49 A GLY 50 n 50 GLY 50 A THR 51 n 51 THR 51 A ASN 52 n 52 ASN 52 A TYR 53 n 53 TYR 53 A TYR 54 n 54 TYR 54 A ILE 55 n 55 ILE 55 A LYS 56 n 56 LYS 56 A VAL 57 n 57 VAL 57 A ARG 58 n 58 ARG 58 A ALA 59 n 59 ALA 59 A GLY 60 n 60 GLY 60 A ASP 61 n 61 ASP 61 A ASN 62 n 62 ASN 62 A LYS 63 n 63 LYS 63 A TYR 64 n 64 TYR 64 A LEU 65 n 65 LEU 65 A HIS 66 n 66 HIS 66 A LEU 67 n 67 LEU 67 A LYS 68 n 68 LYS 68 A VAL 69 n 69 VAL 69 A PHE 70 n 70 PHE 70 A LYS 71 n 71 LYS 71 A SER 72 n 72 SER 72 A LEU 73 n 73 LEU 73 A PRO 74 n 74 PRO 74 A GLY 75 n 75 GLY 75 A GLN 76 n 76 GLN 76 A ASN 77 n 77 ASN 77 A GLU 78 n 78 GLU 78 A ASP 79 n 79 ASP 79 A LEU 80 n 80 LEU 80 A VAL 81 n 81 VAL 81 A LEU 82 n 82 LEU 82 A THR 83 n 83 THR 83 A GLY 84 n 84 GLY 84 A TYR 85 n 85 TYR 85 A GLN 86 n 86 GLN 86 A VAL 87 n 87 VAL 87 A ASP 88 n 88 ASP 88 A LYS 89 n 89 LYS 89 A ASN 90 n 90 ASN 90 A LYS 91 n 91 LYS 91 A ASP 92 n 92 ASP 92 A ASP 93 n 93 ASP 93 A GLU 94 n 94 GLU 94 A LEU 95 n 95 LEU 95 A THR 96 n 96 THR 96 A GLY 97 n 97 GLY 97 A PHE 98 n 98 PHE 98 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 10 A O LYS 10 A N TYR 43 A N TYR 43 A N GLN 46 A N GLN 46 A O ASN 52 A O ASN 52 A O VAL 57 A O VAL 57 A N LEU 65 A N LEU 65 A N GLU 39 A N GLU 39 A O ARG 58 A O ARG 58 A O VAL 57 A O VAL 57 A N LEU 65 A N LEU 65 A N LYS 68 A N LYS 68 A O GLY 84 A O GLY 84 1 A ARG 58 0.240 SIDE CHAIN 1 A PRO 3 -77.53 -169.17 1 A LEU 6 -55.90 -165.43 1 A SER 7 61.29 -88.57 1 A ALA 9 -172.29 149.58 1 A ALA 12 32.66 100.17 1 A LYS 22 -108.17 -73.41 1 A GLU 29 -144.30 20.52 1 A LYS 30 -92.93 -65.75 1 A ASN 32 35.42 42.00 1 A THR 34 -90.51 38.78 1 A TYR 35 -140.51 -152.57 1 A LEU 38 -114.95 60.89 1 A GLU 39 179.05 -151.20 1 A GLN 42 168.84 166.56 1 A VAL 47 -63.25 -158.54 1 A VAL 48 164.85 -50.84 1 A ALA 49 159.50 47.55 1 A THR 51 108.96 93.83 1 A LEU 73 -179.16 60.52 1 A PRO 74 -81.02 49.64 1 A ASN 77 56.73 93.23 1 A ASP 79 45.73 -166.66 1 A LEU 80 -100.34 -147.07 1 A VAL 81 179.20 160.57 1 A THR 83 -55.15 -8.86 1 A TYR 85 165.71 121.91 1 A VAL 87 -90.01 -144.95 1 A ASP 88 -130.19 -144.34 1 A LYS 89 81.88 55.54 1 A ASN 90 39.90 37.58 1 A LYS 91 -105.45 -61.24 1 A GLU 94 -179.10 135.39 1 A LEU 95 -48.27 163.86 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 SOLUTION NMR STRUCTURE OF RECOMBINANT HUMAN CYSTATIN A UNDER THE CONDITION OF PH 3.8 AND 310K 1 Y N A GLU 15 A GLU 15 HELX_P A LYS 22 A LYS 22 1 H1 8 A GLN 26 A GLN 26 HELX_P A LYS 30 A LYS 30 1 H2 5 PROTEINASE INHIBITOR (CYSTEINE) PROTEINASE INHIBITOR (CYSTEINE) CYTA_HUMAN UNP 1 1 P01040 MIPGGLSEAKPATPEIQEIVDKVKPQLEEKTNETYGKLEAVQYKTQVVAGTNYYIKVRAGDNKYMHLKVFKSLPGQNEDL VLTGYQVDKNKDDELTGF 1 98 1CYV 1 98 P01040 A 1 1 98 1 MET engineered mutation LEU 65 1CYV A P01040 UNP 65 65 5 5 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 8 A GLU 8 A PRO 11 A PRO 11 A GLN 42 A GLN 42 A VAL 47 A VAL 47 A GLY 50 A GLY 50 A ALA 59 A ALA 59 A LYS 63 A LYS 63 A SER 72 A SER 72 A LEU 80 A LEU 80 A LEU 82 A LEU 82 A GLU 8 A GLU 8 A PRO 11 A PRO 11 A LEU 38 A LEU 38 A ALA 40 A ALA 40 A GLY 50 A GLY 50 A ALA 59 A ALA 59 A LYS 63 A LYS 63 A SER 72 A SER 72 A GLY 84 A GLY 84 A VAL 87 A VAL 87 1 P 1